Masitinib in Patients with Primary Progressive Multiple Sclerosis (PPMS) or Relapse-Free Secondary Multiple Sclerosis (SPMS) ClinicalTrials.gov, 10 Oct 2011 Accessed on 22 Feb 2012 from http://clinicaltrials.gov/ct2/show/NCT01450488. CommentRecommendBookmarkWatch
